These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of nimodipine, a new calcium antagonist, on ACTH and corticosterone release "in vivo" and "in vitro".
    Author: Costa G, Saija A, Caputi AP.
    Journal: Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):355-67. PubMed ID: 6314455.
    Abstract:
    Intravenous injection of nimodipine (1, 10 and 100 micrograms/Kg) determined a sharp and short-lasting increase in plasma ACTH levels. No change was observed in corticosterone plasma concentration. Intracerebroventricular injection of nimodipine (up to 50 micrograms/rat) did not alter hormone plasma levels. In in vitro experiments, nimodipine (10(-8), 10(-7) and 10(-6) M) did not modify basal and hypothalamic extract-stimulated ACTH release from pituitary tissue, as well as basal release of corticosterone from isolated adrenal glands. However, when adrenal tissue production of corticosterone was stimulated with ACTH, nimodipine (10(-8), 10(-7) and 10(-6) M) showed a powerful and long-lasting inhibitory effect. Data indicate that nimodipine could influence pituitary-adrenal axis by primarily reducing the responsiveness of adrenal glands to ACTH, and exclude a direct effect on hypophysis. It is suggested that the nimodipine-induced reduction of adrenal tissue responsiveness could trigger in vivo a reflex increase in ACTH release, which, in turn, might avoid a decrease in plasma corticosterone levels.
    [Abstract] [Full Text] [Related] [New Search]